Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 82

Biotechnology

Countries begin large-scale screening for SARS-CoV-2 in sewage
Biotechnology | COVID-19 | Diagnostics

Countries begin large-scale screening for SARS-CoV-2 in sewage

On May 14, 2020,The Scientist reported that researchers from several countries including the US, Switzerland, Italy, the Netherlands,…

Read More Countries begin large-scale screening for SARS-CoV-2 in sewageContinue

ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2

On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…

Read More ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2Continue

ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Biotechnology | COVID-19

ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model

On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…

Read More ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium modelContinue

University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19
Biotechnology | COVID-19 | Genomics | Non-Profit Research | Vaccine

University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19

On May 13, 2020, University of Alberta (UA) researchers launched a joint effort with U.S.-based Tonix Pharmaceuticals to…

Read More University of Alberta researchers launched a joint effort with US-based Tonix Pharma to develop and test a vaccine against COVID-19Continue

Thermo Fisher Scientific response to COVID-19 expanded to include new serology test
Biotechnology | COVID-19 | Diagnostics | FDA | Non-Profit Research

Thermo Fisher Scientific response to COVID-19 expanded to include new serology test

On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…

Read More Thermo Fisher Scientific response to COVID-19 expanded to include new serology testContinue

Study confirmed cats can become infected with and may transmit COVID-19 to other cats
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Veterinary

Study confirmed cats can become infected with and may transmit COVID-19 to other cats

On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…

Read More Study confirmed cats can become infected with and may transmit COVID-19 to other catsContinue

National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19

On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…

Read More National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19Continue

National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics | Vaccine

National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19

On May 12, 2020, the National Research Council of Canada (NRC) and the University of Saskatchewan’s (USask) Vaccine…

Read More National Research Council of Canada and USasks VIDO-InterVac collaborated to advance development of vaccine against COVID-19Continue

University of British Columbia Professor Amanda Vincent was named the 2020 winner of the Indianapolis Prize
Biotechnology | Marine Science | Non-Profit Research

University of British Columbia Professor Amanda Vincent was named the 2020 winner of the Indianapolis Prize

On May 12, 2020, University of British Columbia Professor Amanda Vincent, the first biologist to study seahorses in…

Read More University of British Columbia Professor Amanda Vincent was named the 2020 winner of the Indianapolis PrizeContinue

The Jackson Laboratory provided widescale COVID-19 testing in Connecticut
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

The Jackson Laboratory provided widescale COVID-19 testing in Connecticut

On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…

Read More The Jackson Laboratory provided widescale COVID-19 testing in ConnecticutContinue

Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel Coronavirus
Biotechnology | FDA | Infectious Disease | Vaccine

Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel Coronavirus

On May 12, 2020, Moderna announced the U.S. Food and Drug Administration (FDA had granted Fast Track designation…

Read More Moderna received FDA Fast Track Designation for mRNA vaccine (mRNA-1273) against novel CoronavirusContinue

Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality

On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…

Read More Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortalityContinue

Regeneron and Colorado Center for Personalized Medicine announced major new human genetics research collaboration
Biotechnology | Diagnostics | Genomics | Therapeutics

Regeneron and Colorado Center for Personalized Medicine announced major new human genetics research collaboration

On May 11, 2020, Regeneron and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado…

Read More Regeneron and Colorado Center for Personalized Medicine announced major new human genetics research collaborationContinue

Abbott received FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity i  System
Biotechnology | COVID-19 | FDA

Abbott received FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity i System

On May 11, 2020, Abbott announced the FDA issued an Emergency Use Authorization (EUA) for the company’s SARS-CoV-2…

Read More Abbott received FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity i SystemContinue

Novavax received $388 million funding from CEPI for COVID-19 vaccine development and manufacturing
Biotechnology | Infectious Disease | Nanotechnology | Vaccine

Novavax received $388 million funding from CEPI for COVID-19 vaccine development and manufacturing

On May 11, 2020, Novavax announced that the Coalition for Epidemic Preparedness Innovations (CEPI) had committed to investing…

Read More Novavax received $388 million funding from CEPI for COVID-19 vaccine development and manufacturingContinue

Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19
Biotechnology | COVID-19 | FDA | Therapeutics

Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19

On May 11, 2020, Bellerophon Therapeutics announced the FDA accepted its Investigational New Drug (IND) application, allowing the…

Read More Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19Continue

Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kits
Biotechnology | COVID-19 | Diagnostics | FDA | Medical Device

Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kits

On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its…

Read More Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kitsContinue

Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus

On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…

Read More Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel CoronavirusContinue

Arbutus Biopharma announced research initiative to identify novel antiviral therapies for treatment of Coronavirus infections
Biotechnology | COVID-19 | Therapeutics

Arbutus Biopharma announced research initiative to identify novel antiviral therapies for treatment of Coronavirus infections

On May 11, 2020, Arbutus Biopharma announced the establishment of a new research initiative focused on the identification…

Read More Arbutus Biopharma announced research initiative to identify novel antiviral therapies for treatment of Coronavirus infectionsContinue

Fred Hutch, NIH experts outlined plan for COVID-19 vaccines
Biotechnology | COVID-19 | NIH | Non-Profit Research | Vaccine

Fred Hutch, NIH experts outlined plan for COVID-19 vaccines

On May 11, 2020, in a perspective published by the journal Science, Dr. Larry Corey from the Fred…

Read More Fred Hutch, NIH experts outlined plan for COVID-19 vaccinesContinue

Research from University of Washington demonstrated high performance of Abbott’s SARS-CoV-2 antibody blood test
Biotechnology | Diagnostics | Infectious Disease

Research from University of Washington demonstrated high performance of Abbott’s SARS-CoV-2 antibody blood test

On May 8, 2020, Abbott announced new research, published in the Journal of Clinical Microbiology, which found that…

Read More Research from University of Washington demonstrated high performance of Abbott’s SARS-CoV-2 antibody blood testContinue

The  FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients
Biotechnology | COVID-19 | Diagnostics | FDA

The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients

On May 8, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…

Read More The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patientsContinue

RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.
Biotechnology | FDA | Therapeutics

RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.

On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…

Read More RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.Continue

Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assay
Biotechnology | CDC | COVID-19 | FDA

Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assay

On May 8, 2020, Quidel announced it had received Emergency Use Authorization (EUA) from the FDA to market…

Read More Quidel’s received Emergency Authorization for Rapid Antigen COVID-19 diagnostic assayContinue

Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
Biotechnology | COVID-19 | Nanotechnology | Pharmaceutical | Therapeutics | Vaccine

Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine

On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…

Read More Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccineContinue

COVID-19 in-home monitoring program launched
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research

COVID-19 in-home monitoring program launched

On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…

Read More COVID-19 in-home monitoring program launchedContinue

Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs
Biotechnology | COVID-19 | Diagnostics | Medical Device

Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs

On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…

Read More Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabsContinue

Two groundbreaking drugs could combat COVID-19 and its deadliest symptoms
Biotechnology | COVID-19 | Diagnostics | Genomics | Non-Profit Research | Therapeutics

Two groundbreaking drugs could combat COVID-19 and its deadliest symptoms

On May 7, 2020, City of Hope announced that two existing drugs using advanced genomic technology, were being…

Read More Two groundbreaking drugs could combat COVID-19 and its deadliest symptomsContinue

Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19
Biotechnology | COVID-19 | Therapeutics

Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19

On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…

Read More Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19Continue

OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of  Virus causing COVID-19
Biotechnology | COVID-19 | FDA | Medical Device | Non-Profit Research

OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19

On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…

Read More OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19Continue

Page navigation

Previous PagePrevious 1 … 80 81 82 83 84 … 161 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search